Astrazeneca (AZN) EBT (2009 - 2026)
Astrazeneca (AZN) posted EBT of $2.8 billion for Q2 2026, down 10.5% from $3.13 billion a year earlier and down 28.5% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) EBT (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBT at Astrazeneca was $24.06 billion, up 140.0% year-over-year; for FY2025, it came in at $12.4 billion, up 42.7% from FY2024.
- Annual EBT has increased for three consecutive years, with a five-year compound annual growth rate of 25.9% (FY2020 to FY2025).
- In prior years, Astrazeneca's EBT was $8.69 billion in FY2024 (+26.0%), $6.9 billion in FY2023 (+175.8%), $2.5 billion in FY2022 and -$265 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly EBT since Q4 2024.
- On a year-over-year basis, EBT increased in seven of the last eight quarters, with growth averaging 122.1%.
- The strongest year-over-year quarter for EBT in the past five years was Q4 2025, with growth of 746.4%; the weakest was Q2 2022, with a decline of 67.7%.
- According to Business Quant data, EBT for the three prior quarters was $3.91 billion (Q1 2026), $14.1 billion (Q4 2025) and $3.24 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 9.25 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 34.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 4.28 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | -683.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 4.27 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 2.80 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 2.77 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -10.25 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | -653.00 Mn |
| 10 | Vertex Pharmaceuticals | 135.25 Bn | 107.26 Bn | 2.84 Bn | 1.39 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.80 Bn |
| Mar 31, 2026 | 3.91 Bn |
| Dec 31, 2025 | 2.63 Bn |
| Sep 30, 2025 | 3.24 Bn |
| Jun 30, 2025 | 3.13 Bn |
| Mar 31, 2025 | 3.40 Bn |
| Dec 31, 2024 | 1.67 Bn |
| Sep 30, 2024 | 1.83 Bn |
| Jun 30, 2024 | 2.40 Bn |
| Mar 31, 2024 | 2.80 Bn |
| Dec 31, 2023 | 897.00 Mn |
| Sep 30, 2023 | 1.65 Bn |
| Jun 30, 2023 | 2.09 Bn |
| Mar 31, 2023 | 2.26 Bn |
| Dec 31, 2022 | 778.00 Mn |
| Sep 30, 2022 | 922.00 Mn |
| Jun 30, 2022 | 247.00 Mn |
| Mar 31, 2022 | 553.00 Mn |
| Dec 31, 2021 | -636.00 Mn |
| Sep 30, 2021 | -2.00 Bn |
API Access
Astrazeneca EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();